International Board of Directors

2017-2018 Board of Directors

Officers

Timothy P. Howard, CPIP, PE
Chair

Vice President of Strategy and Development
Commissioning Agents, Inc.
Contact
Term: 2017 – 2018

James A. Breen Jr, PE
Vice Chair

Vice President Project Lead Biologics Expansion
Janssen Pharmaceuticals
Contact
Term: 2017 – 2018

President & CEO
Lachman Consultant Services, Inc.
Contact
Term: 2017 – 2018

Vice President of GMP Operations, Biopharm CMC
GlaxoSmithKline
Contact
Term: 2017 – 2018

Michael A. Arnold, RPh
Past Chair

Business Process Owner Investigational Products and Senior Director of Strategic Partnerships
Pfizer's Global Clinical Supply Chain
Contact
Term: 2017 – 2018

John Bournas
Ex officio non-voting member

CEO and President
ISPE
Contact
Term: 2017 – 2018


Directors

Advisor in Global Validation Support
Eli Lilly and Company
Contact
Term: 2016 – 2018 (Second term)

Vice President, Quality Head Solids Americas & Special Technologies
Novartis
Contact
Term: 2016 – 2018 (First term)

Vice President, Global Engineering
Glenmark Pharmaceuticals Inc., USA
Contact
Term: 2017 – 2019 (Second term)

Senior Vice President
Novo Nordisk A/S
Contact
Term: 2017 – 2019 (First term)

Project Portfolio Management, BPm
F Hoffman-La Roche Ltd
Contact
Term: 2017 – 2019 (First term)

Global Head and Executive Director, GRACS CMC – Policy
Merck
Contact
Term: 2016 – 2018 (First term)

Vice President, European Operations
Commissioning Agents, Inc.
Contact
Term: 2017 – 2019 (First term)

Consultant - Laboratory and Quality Systems
Eli Lilly and Company
Contact
Term: 2017 – 2019 (First term)

Chief Technical Officer
MS Pharma
Contact
Term: 2016 – 2018 (First term)

Vice President of Vetter Development Services
Vetter Pharma Fertigung GmbH&Co KG
Contact
Term: 2016 – 2018 (First term)


Ex Officio

 

Board Young Professionals Representative (Non-voting)
Contact
Term: 2017 – 2018


The Call for Nominations for 2018-2020 Board of Directors Candidates is now open. Submit nominations using the Nomination Form by 12 April 2018.

Call for Nominations        Nomination Form

ISPE is governed by an elected board of directors. The board is composed of fifteen elected members and the CEO & President, who serves as a non-voting ex-officio member. Directors are elected to a two-year term and can serve up to two terms consecutively. All terms commence at Annual Meeting. The officer positions are Chair, Vice Chair, Treasurer, Secretary, Past Chair and the President as a non-voting ex officio member. Terms for officers are one year and the Secretary is the first officer position in the typical officer succession. Each candidate for secretary is typically making a five-year commitment to serve in the roles of Secretary through Past Chair. During the September 2016 meeting of the ISPE International Board of Directors, two important modifications were incorporated into the ISPE Bylaws. The Board approved the appointment of a Director level position to the Board and the current Chair of the International Young Professionals Committee will be invited to board meetings as an ex-officio (non-voting) member as well. The main objective of these appointments was to ensure that ISPE has the appropriate diversity within the Board to execute business strategies as defined in our ISPE Strategic Plan. For additional information on the actions from the last Board meeting or access to governance actions visit the Governance Documents FAQs page.